Originally founded in 1980 as AMGen (Applied Molecular Genetics), Amgen pioneered the development of novel and innovative products based on advances in recombinant DNA and molecular biology. Now, Amgen is a leading human therapeutics company in the biotechnology industry.
Amgen has more than thirty-five locations in Canada, Europe, Australia, Asia and the United States, including West Greenwich, Rhode Island. For twenty-five years, the company has tapped the power of scientific discovery and innovation to dramatically improve people's lives. Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.
More than a decade ago, Amgen introduced two of the first biologically derived human therapeutics, EPOGEN® (Epoetin alfa) and NEUPOGEN® (Filgrastim), which became the biotechnology industry's first blockbusters. These products have improved the lives of hundreds of thousands of patients suffering from conditions related to chronic kidney disease and cancer.
Today, Amgen is a Fortune 500 company and its business has expanded to serve patients around the world in supportive cancer care and the treatment of anemia, rheumatoid arthritis and other autoimmune diseases such as psoriatic arthritis and ankylosing spondylitis. Amgen continues to sustain a culture rooted in biotechnology entrepreneurialism and innovation. As a science-based and patient-focused organization, Amgen will follow the science wherever it may lead, to best treat serious illness.
During its history, Amgen has been nationally and internationally recognized for its consistently stellar innovation with awards from respected publications such as Europe's Financial Times, Fortune, IndustryWeek, Pharmaceutical Executive, Science, the Scientist and Forbes among many others.
Amgen's success depends on superior scientific innovation, integrity and continuous improvement in all aspects of its business through the application of the scientific method. Amgen views the scientific method as a multi-step process that includes designing the right experiment, collecting and analyzing data and rational decision making. It is not subjective or emotional, but rather a logical, open and rational process. Applying the scientific method in all parts of the organization is expected and highly valued.
Not only has Amgen focused on advancing science to dramatically improve people's lives, the company has also earned a well-deserved reputation for being a model corporate citizen by conducting itself in the highest ethical manner. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives. In everything Amgen does, it aims to fulfill that mission.